AMBROXOL belongs to a class of drugs called 'mucolytic agents' (cough/sputum thinner) primarily used to treat acute (short term) and chronic (long term) respiratory diseases associated with excess mucus. AMBROXOL is used in the conditions of acute and recurrent bronchitis (airway infection), laryngitis (voice box infection), tracheitis (windpipe infection) and chronic diseases like chronic bronchitis and chronic obstructive pulmonary disease (COPD).

AMBROXOL contains Ambroxol hydrochloride that works by thinning and loosening phlegm (mucus) in the lungs, windpipe and nose. AMBROXOL breaks down the acid mucopolysaccharide fibres and makes the mucous (sputum) thinner and less dense/viscous, removing sputum efficiently by coughing. However, the viscosity of sputum remains low for as long as treatment is maintained.